Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect

Summary:

Evans' syndrome, a combination of autoimmune haemolytic anaemia and autoimmune (idiopathic) thrombocytopenic purpura, is generally harder to treat and more refractory than the single entities. In a male patient with refractory disease, predominantly thrombocytopenic, an allogeneic reduced intensity BMT from his human leukocyte antigen (HLA)-identical sister was followed by a dramatic platelet peak while he was still experiencing initial engraftment (presumably of autologous origin), but subsequently by progressive relapse associated with mixed chimerism. Five gradually incremental DLI achieved complete donor chimerism, which was associated not only with grade II graft-versus-host disease (GVHD), but also with complete clinical and biological remission for 2 years post-transplant. Long-term FU is necessary before claiming that allogeneic stem cell transplantation (SCT) is capable of curing an autoimmune blood disease. However, there is evidence for a graft-versus-autoimmunity effect in this case.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Evans RS, Takahashi K, Duane RT et al. Primary thrombocytopenic purpura and acquired haemolytic anemia. Evidence for a common etiology. Arch Intern Med 1951; 87: 48–65.

    Article  CAS  Google Scholar 

  2. Savasan S, Warrier I, Ravindranath Y . The spectrum of Evans' syndrome. Arch Dis Child 1997; 77: 245–248.

    Article  CAS  Google Scholar 

  3. Portilje JEA, Westendorp RGJ, Kluin-Nelemans HC, Brand A . Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 2001; 97: 2549–2554.

    Article  Google Scholar 

  4. Oyama Y, Papadopoulos EB, Miranda M et al. Allogeneic stem cell transplantation for Evans syndrome. Bone Marrow Transplant 2001; 28: 903–905.

    Article  CAS  Google Scholar 

  5. Marmont AM . Immune ablation and stem cell transplantation for severe Evans syndrome and refractory thrombocytopenic purpura. Bone Marrow Transplant 1999; 23: 1215–1216.

    Article  CAS  Google Scholar 

  6. Musso M, Porretto F, Crescimanno A et al. Autologous peripheral blood stem and progenitor cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus 1998; 7: 492–494.

    Article  CAS  Google Scholar 

  7. Skoda RC, Tichelli A, Tyndall A et al. Autologous peripheral blood stem cell transplantation in refractory thrombocytopenic purpura. Br J Haematol 1997; 99: 56–57.

    Article  CAS  Google Scholar 

  8. Marmont AM, van Lint MT, Occhini D et al. Failure of autologous stem cell transplantation in refractory thrombocytopenic purpura. Bone Marrow Transplant 1998; 22: 227–228.

    Article  Google Scholar 

  9. Lim SH, Kell J, Al-Sabah A et al. Peripheral blood stem cell transplantation for refractory autoimmune thrombocytopenic purpura. Lancet 1997; 340: 475 (letter).

    Article  Google Scholar 

  10. Gratwohl A, Passweg J, Gerber I, Tyndall A . Stem cell transplantation for autoimmune diseases. Best Pract Res Clin Hematol 2001; 14: 755–776.

    Article  CAS  Google Scholar 

  11. Fogarty PF, Huhn RD, Nakamura R et al. Intensive immunosuppression with high-dose cyclophosphamide and autologous CD34+ selected hematopoietic cell support for chronic refractory autoimmune thrombocytopenia (AITP): a follow-up report. Blood 2001; 98: 442 (abstract).

    Article  Google Scholar 

  12. Zaydan MA, Turner C, Miller AM . Resolution of chronic idiopathic thrombocytopenia purpura following syngeneic peripheral blood progenitor transplant. Bone Marrow Transplant. 2002; 29: 87–89.

    Article  CAS  Google Scholar 

  13. Raetz E, Beatty PG, Adams RHO . Treatment of severe Evans syndrome with an allogeneic cord blood transplant. Bone Marrow Transplant 1997; 20: 427–429.

    Article  CAS  Google Scholar 

  14. Couzin J . Gently soothing a savage immune system. Science 2002; 296: 456–458.

    Article  CAS  Google Scholar 

  15. Di Stefano P, Zecca M, Giorgiani G et al. Resolution of immune haemolytic anemia with allogeneic bone marrow transplantation after unsuccessful autograft. Br J Haematol 1999; 106: 1063–1064.

    Article  Google Scholar 

  16. McColl G, Kushaka H, Wicks I . High-dose chemotherapy and syngeneic hemopoietic stem cell transplantation for severe, seronegative rheumatoid arthritis. Ann Intern Med 1999; 131: 550–553.

    Article  Google Scholar 

  17. Antin JH, Childs R, Filipovich AH et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2001; 7: 473–485.

    Article  CAS  Google Scholar 

  18. Dominietto A, Raiola AM, van Lint MT et al. Factors influencing haematological recovery after allogeneic haematopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose. Br J Haematol 2001; 112: 219–227.

    Article  CAS  Google Scholar 

  19. McMillan R . Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol 2000; 37: 239–248.

    Article  CAS  Google Scholar 

  20. Marmont AM . New horizons in the treatment of autoimmune disease: immunoablation and stem cell transplantation. Annu Rev Med 2000; 51: 115–134.

    Article  CAS  Google Scholar 

  21. Li H, Kaufman CL, Boggs SS et al. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J Immunol 1996; 156: 380–387.

    CAS  PubMed  Google Scholar 

  22. Seung E, Iwakoshi N, Woda BA et al. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus host disease induction, of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood 2000; 95: 2175–2182.

    CAS  PubMed  Google Scholar 

  23. Slavin S, Nagler A, Varadi G, Or R . Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28: 853–857.

    Article  CAS  Google Scholar 

  24. Hinterberger W, Hinterberger-Fischer M, Marmont AM . Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favourably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 2002; 30: 733–759.

    Article  Google Scholar 

  25. Dickinson A, Carr A . Haemopoietic stem cell transplantation: improving immune reconstitution, avoiding graft-versus-host disease. Lancet 2002; 360: 98–99.

    Article  Google Scholar 

  26. Burt RK, Slavin S, Burns WH, Marmont AM . Induction of tolerance in autoimmune diseases by haematopoietic stem cell transplantation: getting closer to a cure? Blood 2002; 99: 768–782.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marmont, A., Gualandi, F., van Lint, M. et al. Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant 31, 399–402 (2003). https://doi.org/10.1038/sj.bmt.1703833

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703833

Keywords

This article is cited by

Search

Quick links